Two European countries have temporarily suspended the use of AstraZeneca's COVID vaccine because of concerns over blood clots.
Denmark has paused the jab's rollout for at least two weeks after one person died and three others developed serious conditions.
Norwegian authorities have not given a timeline for their review.
The relevant batch of vaccines was sent in a shipment of 1 million to 17 European countries.
The EU regulator said, "Reports of blood clots received so far are not greater than the number that would have naturally occurred in the vaccinated population."
"The safety of the public will always come first. We are keeping this issue under close review but available evidence does not confirm that the vaccine is the cause."
Denmark has paused the jab's rollout for at least two weeks after one person died and three others developed serious conditions.
Norwegian authorities have not given a timeline for their review.
The relevant batch of vaccines was sent in a shipment of 1 million to 17 European countries.
The EU regulator said, "Reports of blood clots received so far are not greater than the number that would have naturally occurred in the vaccinated population."
"The safety of the public will always come first. We are keeping this issue under close review but available evidence does not confirm that the vaccine is the cause."
- Category
- DENMARK
Commenting disabled.